#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15452	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2561	742.6	0	.	n	.	0	C1450T	SNP	1450	1450	C	1896	1896	T	1000	T,C	996,4	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15452	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2561	742.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1630	1630	C	961	C,G,A	958,2,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26542	23S	2890	2890	99.93	23S.l15.c17.ctg.1	4058	814.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1934	1934	A	1111	A,C	1110,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26542	23S	2890	2890	99.93	23S.l15.c17.ctg.1	4058	814.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2568	2568	C	926	C,A	924,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26542	23S	2890	2890	99.93	23S.l15.c17.ctg.1	4058	814.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2642	2642	A	945	A,T,G	943,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26542	23S	2890	2890	99.93	23S.l15.c17.ctg.1	4058	814.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	3194	3194	C	919	C,T,G,A	914,1,2,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_W_01420c	folP.WHO_W_01420c	1	1	539	2224	folP	852	852	99.88	folP.l6.c4.ctg.1	2019	136.9	0	.	p	.	0	E151K	NONSYN	451	453	GAA	1010	1012	AAA	217;210;211	A,C;A;A	216,1;210;211	.	.
folP.WHO_W_01420c	folP.WHO_W_01420c	1	1	539	2224	folP	852	852	99.88	folP.l6.c4.ctg.1	2019	136.9	1	SNP	p	R228S	1	.	.	682	684	AGC	1241	1243	AGC	204;206;206	A,C;G;C	203,1;206;206	folP.WHO_W_01420c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5232	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	4021	162.2	1	SNP	p	S91F	0	.	.	271	273	TCC	871	873	TCC	180;182;183	T;C;C	180;182;183	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5232	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	4021	162.2	1	SNP	p	D95G	0	.	.	283	285	GAC	883	885	GAC	185;188;186	G;A;C	185;188;186	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5232	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	4021	162.2	1	SNP	p	D95N	0	.	.	283	285	GAC	883	885	GAC	185;188;186	G;A;C	185;188;186	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	2154	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1716	155.6	1	SNP	p	G45D	0	.	.	133	135	GGC	689	691	GGC	246;246;248	G;G;C	246;246;248	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1120	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1612	86.6	0	.	n	.	0	A197.	DEL	197	197	A	892	892	A	211	A	211	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5114	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3505	181.7	1	SNP	p	D86N	0	.	.	256	258	GAC	935	937	GAC	240;236;236	G;A;C	240;236;236	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5114	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3505	181.7	1	SNP	p	S87R	0	.	.	259	261	AGT	938	940	AGT	237;233;234	A;G;T,C	237;233;233,1	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5114	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3505	181.7	1	SNP	p	S87I	0	.	.	259	261	AGT	938	940	AGT	237;233;234	A;G;T,C	237;233;233,1	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5114	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3505	181.7	1	SNP	p	S87W	0	.	.	259	261	AGT	938	940	AGT	237;233;234	A;G;T,C	237;233;233,1	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5114	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3505	181.7	1	SNP	p	S88P	0	.	.	262	264	TCC	941	943	TCC	239;240;236	T,G;C;C	238,1;240;236	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4434	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3190	173.3	0	.	p	.	0	A157V	NONSYN	469	471	GCA	1040	1042	GTA	239;241;243	G;T;A,G	239;241;242,1	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4434	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3190	173.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1799	1801	GGC	257;252;253	G,T,C;G;C,A	255,1,1;252;252,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4338	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3018	179.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1590	1592	GCA	278;277;282	G;C;A	278;277;282	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4338	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3018	179.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1593	1595	ATC	278;277;279	A,T,C;T,A;C	276,1,1;276,1;279	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4338	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3018	179.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1605	1607	GTG	300;300;297	G;T,C;G	300;299,1;297	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4338	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3018	179.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1605	1607	GTG	300;300;297	G;T,C;G	300;299,1;297	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4338	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3018	179.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2109	2111	ACC	240;241;243	A;C,G,A;C	240;239,1,1;243	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4338	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3018	179.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2163	2165	GCG	225;227;227	G;C,G;G,A	225;226,1;225,1	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4338	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3018	179.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2163	2165	GCG	225;227;227	G;C,G;G,A	225;226,1;225,1	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4338	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3018	179.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2286	2288	GGC	238;237;237	G;G,A;C	238;236,1;237	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4338	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3018	179.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2295	2297	GGC	228;226;227	G,T;G;C	227,1;226;227	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4338	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3018	179.2	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2313	2315	CTG	236;234;236	C;T,C,A;G	236;232,1,1;236	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6056	ponA	2397	2397	100.0	ponA.l6.c17.ctg.1	3586	210.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1883	1885	CCG	241;243;242	C,G;C,A;G,A	239,2;242,1;241,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2574	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2252	142.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	751	751	C	183	C	183	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	262	porB1a	984	100	94.0	porB1a.l15.c4.ctg.3	179	44.6	0	.	p	.	0	M18T	NONSYN	52	54	ATG	130	132	ACG	49;46;46	A;C;G	49;46;46	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	262	porB1a	984	100	94.0	porB1a.l15.c4.ctg.3	179	44.6	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	172	174	CAA	15;15;12	C;A;A	15;15;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	262	porB1a	984	156	92.95	porB1a.l15.c4.ctg.4	156	45.6	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	15;18;18	T;T;A	15;18;18	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	262	porB1a	984	156	92.95	porB1a.l15.c4.ctg.4	156	45.6	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	57;57;57	C;A;T	57;57;57	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	262	porB1a	984	156	92.95	porB1a.l15.c4.ctg.4	156	45.6	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	57;57;57	A;G;T	57;57;57	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	262	porB1a	984	156	92.95	porB1a.l15.c4.ctg.4	156	45.6	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	57;57;57	T,G;A;C	56,1;57;57	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3032	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	2096	180.4	0	.	p	.	0	N38E	NONSYN	112	114	AAT	696	698	GAA	282;281;281	G;A;A	282;281;281	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3032	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	2096	180.4	0	.	p	.	0	N134D	NONSYN	400	402	AAT	984	986	GAT	262;265;264	G;A,T,C;T,G	262;263,1,1;263,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3032	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	2096	180.4	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1107	1109	TCA	258;261;259	T;C;A	258;261;259	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3032	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	2096	180.4	0	.	p	.	0	S217F	NONSYN	649	651	AGT	1233	1235	TTT	252;257;259	T;T;T,C	252;257;257,2	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3032	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	2096	180.4	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1236	1238	GTC	255;252;248	G;TCCCC,TCCC;C	255;235,1;248	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3032	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	2096	180.4	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1566	1568	GCA	239;239;237	G,A;C;A,C	237,1;238;236,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3032	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	2096	180.4	1	SNP	p	G120K	1	.	.	358	360	AAG	942	944	AAG	242;241;241	A;A;G	242;241;241	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3032	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	2096	180.4	1	SNP	p	A121D	1	.	.	361	363	GAC	945	947	GAC	241;242;246	G,A;A;C	240,1;242;246	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3032	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	2096	180.4	1	SNP	p	D121N	0	.	.	361	363	GAC	945	947	GAC	241;242;246	G,A;A;C	240,1;242;246	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	10546	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5442	241.5	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2311	2313	AAT	286;291;294	A;A;T	286;291;294	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1666	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1505	137.9	1	SNP	p	V57M	1	.	.	169	171	ATG	825	827	ATG	307;307;310	A,C;T,G;G,T	306,1;306,1;308,2	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
